Displaying 301-350 of 1173 result(s).
Recent Articles
- IceCure Medical Sees 36% Revenue Increase Amid ProSense Growth
- Westgate Energy Reports Impressive Q3 2024 Growth Metrics
- TEN Ltd. Posts Strong Nine-Month Performance and Announces Dividends
- Altimmune to Showcase Innovations at Key Investor Conferences
- NeuroNOS Welcomes Nobel Laureate Roger D. Kornberg to Board
- BriaCell Highlights New Survival Data in Metastatic Breast Cancer
- Jim Cramer Highlights Linde's Potential Amid Stock Surge
- Brazil's Rising Inflation Signals Potential Rate Hikes Ahead
- Nano Dimension Encourages Shareholders to Support Board Changes
- Nigeria's Central Bank Adjusts Key Interest Rate to 27.50%
- Rivian Automotive's Strategic $6.6 Billion DOE Loan Boosts Shares
- H&M Faces Challenges Amid RBC Downgrade and Market Pressures
- S&P 500 Expected to Surge 8% by 2025 Supported by Rate Cuts
- Charles Hoskinson Envisions Cardano Revolutionizing Bitcoin
- Exploring Promising Solar Investments Amid Political Changes
- Investors Alert: Class Action Lawsuit Filed Against Zeta Global
- Leslie's Faces Tough Market After Disappointing Earnings Report
- Market Watch: Analyst Downgrades That Could Affect Your Portfolio
- Warning Signs for These Three Industrials Stocks This Quarter
- Transforming Solar Access: The Impact of TAG's Innovations
- Exciting Treehouse Hotel Silicon Valley Now Open for Bookings
- Exploring Antimony's Price Surge: Impacts on Industry and Investment
- NEXE Innovations Partners with Bridgehead Coffee for Growth
- Leadership Changes at Northstar Aim to Fuel Future Growth
- Innovative Waveguide Smart Glasses by Vuzix at CES 2025
- Google's AdTech Trial Closes with High Stakes Arguments
- Intel Secures Nearly $8 Billion for Semiconductor Growth
- US Building Permits Show Signs of Stabilization Amid Decline
- Best Buy Reports Q3 Performance and Adjusted Future Expectations
- VerifyMe Expands Share Buyback Program Through 2025
- H World Group Limited Reports Q3 2024 Financial Highlights
- Esperion's Innovative Cholesterol Drug Seeks Approval in Japan
- Eos Energy Partners with Wabash for Enhanced Battery Solutions
- Sonder Holdings Faces Nasdaq Compliance Challenges Ahead
- OpenText Welcomes Cisco Leader to Enhance Board Dynamics
- Xeros Technology Group Sees Major Shift in Shareholdings
- Shareholder Meetings Set for Fondul Proprietatea’s Board Nominees
- TOYO Co. Secures Major Solar Cell Contract Boosting Future
- UroGen Pharma's JELMYTO: A Revolutionary Long-term Treatment
- Maxeon Solar's Strategic Shift: Emphasizing U.S. Operations
- Barclays Warns of Potential Market Bubble Following Elections
- Wells Fargo's Path to Removing Asset Cap: Key Insights Ahead
- Auto Industry Reacts to Trump's Proposed Tariffs on Imports
- Cabaletta Bio: Upcoming Conferences for Investors Wisdom
- Freshworks Takes Center Stage at UBS Global Technology Event
- Renexxion Ireland Ltd. Expands Intellectual Property Portfolio
- Gentex Corporation Declares Quarterly Dividend for Investors
- Keros Therapeutics to Present Key Developments at Conferences
- X4 Pharmaceuticals to Showcase Innovations at Notable Conference
- ALX Oncology Leadership to Speak at Upcoming Healthcare Event